(Q53154285)

11 May 2018

title

Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma. (English)

1 reference

11 May 2018

1 reference

Valérian Dormoy

1

0 references

Thierry Massfelder

9

Thierry Massfelder

1 reference

11 May 2018

Mariette Barthelmebs

5

Mariette Barthelmebs

1 reference

11 May 2018

Catherine Coquard

4

Catherine Coquard

1 reference

11 May 2018

Véronique Lindner

3

Véronique Lindner

1 reference

11 May 2018

author name string

Claire Béraud

2

1 reference

11 May 2018

David Brasse

6

1 reference

11 May 2018

Didier Jacqmin

7

1 reference

11 May 2018

Hervé Lang

8

1 reference

11 May 2018

language of work or name

English

0 references

publication date

28 July 2012

1 reference

11 May 2018

published in

Carcinogenesis

1 reference

11 May 2018

volume

33

1 reference

11 May 2018

issue

11

1 reference

11 May 2018

page(s)

2084-2093

1 reference

11 May 2018

The changing pattern of kidney cancer incidence and mortality in Europe

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The epidemiology of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Parathyroid hormone-related protein in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Von Hippel-Lindau disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Expression and clinical significance of Notch receptors in human renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

In vivo validation of PAX2 as a target for renal cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin d pathway genes, diet, and risk of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Assessing the efficacy of the hedgehog pathway inhibitor vitamin D3 in a murine xenograft model for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The role of Vitamin D3 metabolism in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Health effects of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin D and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Benefit-risk assessment of vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin D in combination cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Prevention of renal cell carcinoma by active vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Angiogenesis and angiogenic inhibitors in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Anti-angiogenic therapy in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Signaling pathways in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

New vitamin D analogs and changing therapeutic paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGS255

1 reference

11 May 2018

PubMed ID

22843547

1 reference

11 May 2018